Об авторах
Айтышова Динара Кубатбековна, врач радиогинеколог, отд. радиогинекологии, Национального центра онкологии и гематологии, Бишкек, Кыргызская Республика
Макимбетов Эмил Кожошович, доктор медицинских наук, зав. каф. онкологии Кыргызско-Российского Славянского Университета имени первого Президента Российской Федерации Б.Н. Ельцина, Бишкек, Кыргызская Республика
Aityshova Dinara Kubatbekovna, radiogynecologist, dept. Radiogynecology, National Center of Oncology and Hematology, Bishkek, Kyrgyz Republic
Makimbetov Emil Kozhoshovich, Doctor of Medical Sciences, Head of the Department of Oncology, Kyrgyz-Russian Slavic University named after the first President of the Russian Federation B.N. Yeltsin, Bishkek, Kyrgyz Republic
Айтышова Динара Кубатбековна, Улуттук онкология жана гематология борборунун радиогинекология бөлүмүнүн радиогинекологу, Бишкек, Кыргыз Республикасы
Макимбетов Эмил Кожошович, медицина илимдеринин доктору, Россия Федерациясынын биринчи президенти Б.Н. атындагы Кыргыз-Орус Славян университетинин онкология кафедрасынын башчысы. Ельцин, Бишкек, Кыргыз Республикасы
Список литературы
1. Barlow EL, Kang YJ, Hacker NF, Canfell K. Changing trends in vulvar cancer incidence and mortality rates in Australia since
1982. Int J Gynecol Cancer. 2015;25:1683‐1689.
2. Kang YJ, Smith M, Barlow E, Coffey K, Hacker N, Canfell K. Vulvar cancer in high‐income countries: increasing burden of
disease. Int J Cancer. 2017;141:2174‐2186.
3. Butt JL, Botha MH. Vulvar cancer is not a disease of the elderly: treatment and outcome at a tertiary referral centre in South
Africa. S Afr Med J. 2017;107:1000‐1004.
4. Muigai J, Jacob L, Dinas K, Kostev K, Kalder M. Potential delay in the diagnosis of vulvar cancer and associated risk factors
in women treated in German gynecological practices. Oncotarget. 2018;9:8725‐8730.
5. Xiao X, Meng Y‐B, Bai P, et al. Vulvar cancer in China: epidemiological features and risk analysis. J Cancer.
2017;8:2950‐2958.
6. Coleman RL, Ali S, Levenback CF, et al. Is bilateral lymphadenectomy for midline squamous carcinoma of the vulva always
necessary? An analysis from Gynecologic Oncology Group (GOG) 173. Gynecol Oncol. 2013;128:155‐159.
1. Barlow EL, Kang YJ, Hacker NF, Canfell K. Changing trends in vulvar cancer incidence and mortality rates in Australia since
1982. Int J Gynecol Cancer. 2015;25:1683‐1689.
2. Kang YJ, Smith M, Barlow E, Coffey K, Hacker N, Canfell K. Vulvar cancer in high‐income countries: increasing burden of
disease. Int J Cancer. 2017;141:2174‐2186.
3. Butt JL, Botha MH. Vulvar cancer is not a disease of the elderly: treatment and outcome at a tertiary referral centre in South
Africa. S Afr Med J. 2017;107:1000‐1004.
4. Muigai J, Jacob L, Dinas K, Kostev K, Kalder M. Potential delay in the diagnosis of vulvar cancer and associated risk factors
in women treated in German gynecological practices. Oncotarget. 2018;9:8725‐8730.
5. Xiao X, Meng Y‐B, Bai P, et al. Vulvar cancer in China: epidemiological features and risk analysis. J Cancer.
2017;8:2950‐2958.
6. Coleman RL, Ali S, Levenback CF, et al. Is bilateral lymphadenectomy for midline squamous carcinoma of the vulva always
necessary? An analysis from Gynecologic Oncology Group (GOG) 173. Gynecol Oncol. 2013;128:155‐159.
1. Barlow EL, Kang YJ, Hacker NF, Canfell K. Changing trends in vulvar cancer incidence and mortality rates in Australia since
1982. Int J Gynecol Cancer. 2015;25:1683‐1689.
2. Kang YJ, Smith M, Barlow E, Coffey K, Hacker N, Canfell K. Vulvar cancer in high‐income countries: increasing burden of
disease. Int J Cancer. 2017;141:2174‐2186.
3. Butt JL, Botha MH. Vulvar cancer is not a disease of the elderly: treatment and outcome at a tertiary referral centre in South
Africa. S Afr Med J. 2017;107:1000‐1004.
4. Muigai J, Jacob L, Dinas K, Kostev K, Kalder M. Potential delay in the diagnosis of vulvar cancer and associated risk factors
in women treated in German gynecological practices. Oncotarget. 2018;9:8725‐8730.
5. Xiao X, Meng Y‐B, Bai P, et al. Vulvar cancer in China: epidemiological features and risk analysis. J Cancer.
2017;8:2950‐2958.
6. Coleman RL, Ali S, Levenback CF, et al. Is bilateral lymphadenectomy for midline squamous carcinoma of the vulva always
necessary? An analysis from Gynecologic Oncology Group (GOG) 173. Gynecol Oncol. 2013;128:155‐159.
